Drugs / Stillen Tab.
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01817556 | Oct 2012 → Oct 2013 | chronic gastritis | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT06151210 Comparator | Jan 2024 → Jul 2025 | chronic gastritis | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT02282670 Comparator | Apr → Nov 2014 | chronic gastritis | Dong-A ST Co., Ltd. | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT07631065 Comparator | Jun 2026 → Feb 2028 expected | chronic gastritis | Mather's Pharm. Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stillen tab. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02282670 ↗ |
| Route | Oral | “Stillen Tab., oral” NCT07631065 ↗ |